cysteamine and Neoplasm Metastasis
cysteamine has been researched along with Neoplasm Metastasis in 4 studies
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Fujisawa, T; Gahl, WA; Joshi, BH; Patel, PS; Puri, RK; Rubin, B; Suzuki, A | 1 |
ISAEV, MS | 1 |
Godenèche, D; Kim-Triana, B; Madelmont, JC; Mathé, G; Misset, JL; Musset, M | 1 |
Baker, DG; Lowy, RO | 1 |
Other Studies
4 other study(ies) available for cysteamine and Neoplasm Metastasis
Article | Year |
---|---|
Cysteamine suppresses invasion, metastasis and prolongs survival by inhibiting matrix metalloproteinases in a mouse model of human pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Survival; Cysteamine; Disease Models, Animal; Enzyme Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Neoplasm Metastasis; Pancreatic Neoplasms; Tumor Cells, Cultured | 2012 |
[FEATURES OF METASTASIS OF GEUREN'S CARCINOMA FOLLOWING THE ACTION OF RADIATION ENERGY COMBINED WITH THE USE OF BETA-MERCAPTOETHYLAMINE].
Topics: Carcinoma; Cysteamine; Mercaptoethylamines; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Pharmacology; Radiation; Rats; Research | 1964 |
Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow Diseases; Cysteamine; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Nitrosourea Compounds | 1992 |
Effect of radioprotective drugs on the therapeutic ratio for a mouse tumor system.
Topics: Animals; Cysteamine; Dose-Response Relationship, Radiation; Female; Lung Neoplasms; Methods; Mice; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Transplantation; Phosphoric Acids; Radiation Injuries, Experimental; Radiation-Protective Agents; Radiodermatitis; Radiotherapy Dosage; Sarcoma, Experimental; Skin Neoplasms; Sulfur; Time Factors; Transplantation, Homologous | 1973 |